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West Nile Virus (WNV) is a mosquito-borne flavivirus that was introduced into the U.S. in the New York City area in 1999. Despite its
successful establishment and rapid spread in a naive environment, WNV has undergone limited evolution since its introduction. This evolutionary
stability has been attributed to compromises made to permit alternating cycles of viral replication in vertebrate hosts and arthropod vectors.
Outbreaks of a close relative of WNV, St. Louis encephalitis virus (SLEV), occur in the U.S. periodically and are also characterized by limited
genetic change overtime. We measured both phenotypic and genotypic changes in WNV and SLEV serially passaged in mosquito cell culture in
order to clarify the role of an individual host cell type in flavivirus adaptation and evolution. Genetic changes in passaged WNV and SLEV were
minimal but led to increased relative fitness and replicative ability of the virus in the homologous cell line C6/36 mosquito cells. Similar increases
were not measured in the heterologous cell line DF-1 avian cells. These phenotypic changes are consistent with the concept of cell-specific
adaptation in flaviviruses.
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West Nile Virus (WNV) is a mosquito-borne flavivirus that
was introduced into the U.S. in the New York City area in 1999.
Since its introduction, WNV has spread rapidly across the U.S.
and into Canada, Mexico, and Central and South America
(Lanciotti et al., 1999; Dupuis et al., 2003; 2005; Austin et al.,
2004). Outbreaks of its close relative, St. Louis encephalitis
virus (SLEV), occur in the U.S. periodically (Chandler et al.,
2001; Day and Stark, 2000). Understanding the adaptability and
selective pressures that drive genetic and phenotypic changes in
these viruses is crucial to predicting their ability to persist and re-
emerge.
Both WNV and SLEV are maintained in nature in enzootic
cycles in which they are transmitted between ornithophilic
mosquitoes and avian hosts. Non-avian vertebrates become⁎ Corresponding author.
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doi:10.1016/j.virol.2006.08.005infected as a result of feeding by infected vectors, but virus is
generally not perpetuated in this manner, due to the low level of
viremia in most non-avian, vertebrate hosts (Kramer and
Bernard, 2001). Evolutionary pressures on the virus, therefore,
are applied predominately by the mosquito and avian
environments.
RNAviruses have the capacity for rapid evolution due to their
high mutation rates, short replication times, and large population
sizes (Drake and Holland, 1999). Despite this, rapid rates of
evolution have not been observed with arboviruses (Cilnis et al.,
1996; Jenkins et al., 2002; Weaver et al., 1992). It has been
shown, for example, that WNV has undergone limited evolution
in the years during which it has been circulating in the U.S.
(Davis et al., 2005; Ebel et al., 2001, 2004). The case of WNV is
particularly interesting because the virus's genotypic stability
has not compromised its ability to succeed in new environments.
One hypothesis for this genetic conservation is that the alternate
cycles of viral replication in vertebrate hosts and arthropod
vectors constrain evolution (Scott et al., 1994; Weaver et al.,
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made regularly by virus populations, in both the arthropod
vectors and vertebrate hosts, due to differential selection in each.
Specifically, mutations exclusively advantageous to either host
are purged by purifying selection if they are detrimental to
replication in the alternative host; positive selection then
generally results from the infrequent mutations that result in
coadaptation. Reduced positive selection and increased purify-
ing selection in vector-borne RNA viruses have been reported
previously (Holmes, 2003; Jerzak et al., 2005; Woelk and
Holmes, 2002). Further phenotypic and genotypic evidence for
replicative compromises has been provided by previous studies
including those on the flavivirus dengue 2 (Chen et al., 2003) and
the togaviruses Sindbis (SINV) (Greene et al., 2005) and eastern
equine encephalitis (EEEV) (Cooper and Scott, 2001; Weaver et
al., 1999). However, different results were obtainedwhen studies
were performed with the rhabdovirus vesicular stomatitis virus
(VSV) (Novella et al., 999; Zarate and Novella, 2004).
We assessed individual relative fitness, replicative ability,
and genetic alterations of both WNV and SLEV during serial
passage in C6/36 cell culture in order to better characterize the
evolutionary pressures and adaptive ability of flaviviruses
replicating in mosquito cells. Specifically, we sought to clarify
the extent to which these flaviviruses are capable of cell-
specific adaptation and the degree to which this adaptation
alters both fitness in other cell types and genetic sequences. We
hypothesized that adaptation to a single cell type would lead to
decreases in viral fitness in the bypassed cell. Understanding
the spectrum of phenotypic changes and degree of genetic
alteration in virus serially passaged in a single host cell type
will help us to understand the evolutionary stability observed
in virus cycling in nature.Fig. 1. Replication in different three cell lines of WNV (A) and SLEV (B) unpassag
Multiplicity of infection for all growth curves is 0.1 PFU/cell. Arrows indicate the tResults
Changes in relative fitness of WNV and SLEV following serial
passage in mosquito cells
Competition assays to measure the relative fitness of WNV
and SLEV were based on co-infection of three different cell
lines with a mixture of test (biologically cloned virus) and
control (monoclonal antibody [MAb] resistant mutant; MARM)
virus. Growth curves were analyzed to confirm that replication
of WNV and SLEV and their respective MARM is similar in
each cell line (Fig. 1). Time of virus harvest for competition
assays in each cell line was selected based on the time at which
the peak titers of the test and control viruses were similar.
Consequently, WNV competition assays were carried out for
48, 72, and 96 h post inoculation (hpi) in Vero (mammalian),
DF-1 (avian), and C6/36 (mosquito) cells, respectively, and
SLEV competition assays were harvested at 96 hpi in C6/36
cells and 48 hpi in DF-1 and Vero cells (Fig. 1). Although titers
of SLEV and its MARM began to diverge at 48 hpi in DF-1
cells, the assays were harvested at a time at which neither strain
had a significant replicative advantage.
The results of competition assays measuring the relative
fitness values of WNV and SLEV in three different cell lines
are summarized in Fig. 2. Changes in unpassaged virus:
MARM ratios were minimal during competition. Ratios
fluctuated slightly in all cell lines for both viruses but were
never significantly different from input ratios in any round of
competition (data not shown). Values were adjusted such that
a relative fitness value of 0 was assigned to these controls.
Therefore, relative fitness values accurately represent changes
resulting from passaging such that a positive value representsed biological clones (UP) and monoclonal antibody resistant mutants (MARM).
ime of harvest for competition assays.
Fig. 2. Relative fitness values ofWNVand SLEVafter passage in C6/36 cells and
competition in three cell lines. Three to four independent C6/36 cell passage
lineages, designated A, B, C, and D, were tested in each cell line and vector plots
were constructed. Relative fitness values represent slopes calculated after
normalizing the ratio for each round to the ratio of the initial input and plotting
these values against the competition round. Each competition assay was
performed in triplicate, and the average fitness values are presented here. In order
to measure changes resulting from passaging, all values were adjusted further by
normalizing to relative fitness of unpassaged virus controls, and slopes were
compared by ANCOVA (GraphPad Prism, Version 4.0) to determine if
significant fitness changes had occurred (*P<0.05).
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in relative fitness.
Competition assays performed in the mosquito cell line C6/
36 resulted in relative fitness gains for all lineages of WNVand
SLEV after serial passage in C6/36 cells. These gains were
significant in two of three lineages after 10 passages for WNV
(WNV CP10) (P<0.05) and were highly significant in all three
lineages by passage 19 (WNV CP19) (P<0.001) (Fig. 2A).
Fitness continued to increase to passage 39 (WNVCP39), with a
relative fitness advantage of approximately 1 (equivalent to 1
log10 increase per round of competition). Overall, the rate and
magnitude of fitness gains for SLEV were greater than those of
WNV (Fig. 2B). After three passages (SLE CP3), all SLEV
lineages increased in fitness significantly (P<0.01). Fitness
gains substantially increased and appeared to be maximized by
passage 20 (SLE CP20) in two of four lineages. The remaining
two lineages continued to gain in fitness to passage 40 (SLE
CP40). SLEV relative fitness advantages ranged from approxi-
mately 1.5 to 2 for SLE CP40.
Competition assays of C6/36-passaged virus populations
were performed in avian cells (DF-1) to determine whether anincreased competitive advantage in mosquito cells affected
fitness in the natural alternative host cell line (Fig. 2).
Measurements of relative fitness are equivalent to normalized
slopes of vector plots resulting from serial rounds of
competition (see Materials and methods). A representation of
how all vector plots were constructed is shown in plaque assay
portion of Fig. 3. With the exception of SLE CP3, increases in
relative fitness were not observed in any lineage of either virus
in avian cells (Fig. 2B). All three lineages of C6/36-passaged
SLEV and WNV exhibited slight decreases in fitness in avian
cells, but these decreases were statistically significant
(P<0.05) for only one lineage of each virus. Furthermore,
no decreases were comparable in magnitude to the increases
measured in C6/36 cells.
The results of competition assays performed in Vero cells
were more variable. Some lineages of C6/36-passaged viruses
demonstrated no fitness changes, while others incurred modest
increases or decreases in relative fitness at various passage
numbers. Some of these differences were statistically sig-
nificant, but none was comparable to the increases seen in C6/
36 cell competition assays.
The competition assay results (Fig. 2) were based on plaque
titration on Vero cells in the presence or absence of MAb. The
gains in relative fitness of infectious SLEV determined by
plaque assay were compared, for representative samples, to
trends measured by RT-PCR assays designed to distinguish the
amount of test and control virus RNA in samples. Although
some of the slopes in the fitness vector plots of two C6/36 cell
passage lineages (A and C) are steeper (higher relative fitness)
with plaque assay quantitation, similar trends were measured
with RT-PCR analysis (Fig. 3). The differences in magnitude of
relative fitness measurements for passaged SLEV can be
attributed to an increase in cross reactivity of SLE Kern and
MARM as ratios increase. Experiments with control mixtures
determined that cross reactivity begins to affect accuracy of
quantitation at approximately 100:1 and increases with further
gains (data not shown). For this reason, fitness advantages for
SLE CP20 and SLE CP40 are dampened somewhat in later
rounds of competition when assessed by RT-PCR. Statistically,
results from both plaque and RT-PCR assays for lineages A
and C demonstrated that SLE CP20 and SLE CP40 had relative
fitness values that were significantly greater than relative
fitness values of unpassaged SLEV (SLE UP) (P<0.05). SLE
CP3 results were more variable. For lineage A, the plaque
assay demonstrated that SLE CP3 relative fitness was
significantly greater than SLE UP relative fitness and less
than SLE CP20 and CP40 relative fitness, thus showing a
gradual gain in fitness during serial passaging. This difference
was not seen for lineage C by plaque assay or for either lineage
by RT-PCR.
Changes in viral growth patterns following serial passage in
mosquito cells
Individual growth curves were analyzed in both mosquito
and avian cells to determine whether fitness gains correlated
with replicative advantages for passaged viruses. Both WNV
Fig. 3. Comparison of the relative fitness of C6/36-passed SLEV, measured by plaque assay and RT-PCR. Four rounds of competition between test (unpassaged SLEV
and passages 3, 20, and 40) and control (MARM) viruses were completed in triplicate in C6/36 cells. Each round consisted of 96 h of competitive replication. Changes
in ratios of test:control virus were quantified by Vero cell plaque assay (duplicate) or real-time RT-PCR (triplicate). An MOI of 0.01 was maintained for each round of
infection.
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to unpassaged virus following passage in C6/36 cells (Figs. 4A
and B). For WNV, a difference in mean titer between passaged
(WNV CP19 and WNV CP39) and unpassaged virus (WNV
UP) was observed by 24 hpi, and the difference increasedFig. 4. Replication of C6/36 passaged (CP) and unpassaged viruses (UP) in C6/36 and
Results are presented as the means±SD of duplicate or triplicate assays. (A)WNVrep
replication in DF-1 cell culture. (D) SLE replication in DF-1 cell culture.through 96 hpi when it peaked with a greater than 100-fold
advantage of passaged virus (Fig. 4A). This peak corresponded
to the harvest time for competition assays and reflected the
increase in relative fitness measured by competition assay. A
difference in titer betweenWNV CP19 andWNV CP39 was notDF-1 cell culture. Multiplicity of infection for all growth curves is 0.01 PFU/cell.
lication in C6/36 cell culture. (B) SLE replication in C6/36 cell culture. (C)WNV
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relative fitness (Fig. 2A).
C6/36-passed SLEValso demonstrated an accelerated rate of
replication in C6/36 cells, resulting in differences 2.5 and 3.5
log10 plaque forming units (PFU)/ml by 24 hpi for SLE CP20
and CP40, respectively (Fig. 4B). The differences in titer
decreased to 1–2 log10 PFU/ml (SLE CP20) and 2–3 log10
PFU/ml (SLE CP40) at 48 hpi. Although these results are
consistent with the accelerated fitness values measured by
competition assay with SLEV (Fig. 2B), they differ slightly in
that SLE CP40 had a replicative advantage over SLE CP20
despite no measurable difference in relative fitness.
Neither SLEV nor WNV showed similar gains when growth
curves were analyzed following infection in avian cells,
indicating a specific adaptation to mosquito cells following
passage in these cells (Figs. 4C and D). There were no
measurable differences in replicative ability between passaged
and unpassaged WNV in avian cells (Fig. 4C), and passaged
SLEV displayed only moderately decreased replicative ability
in avian cells (Fig. 4D).
Genetic changes in WNV and SLEV following serial passages
in mosquito cells
Genetic changes resulting from passage of WNV and SLEV
in mosquito cells were identified in the nucleotide sequences of
the full-length genomes of unpassaged and passaged virus from
representative lineages (Table 1). Although relatively few
mutations accumulated during passaging of either virus, more
mutations were identified in SLEV than in WNV (8 vs. 3). Only
three mutations were generated in the full-length genome of
WNV CP39, two of which were nonsynonymous. Both of the
resultant amino acid changes were conservative. One change
occurred at nucleotide position 1712 of the envelope in WNV
CP39, but this change was not identified in WNV CP19, by
which time an increase in viral fitness had been demonstrated.
One amino acid change also occurred in NS4A, a nonstructuralTable 1
Nucleotide (NT) and amino acid (AA) changes in sequences of C6/36-passaged
WNV and SLEV populations relative to unpassaged clonal populations
following full-genome analyses
Virus NT position Region NT change AA change
WNV CP19 6687 NS4A G→T Q→H
WNV CP39 1712 ENV A→G K→R
3663 NS2A T→C None
6687 NS4A G→T Q→H
SLEV CP20 a 679 prM A→G E→G
6720 NS4A T→A T→A
SLEV CP40 679 prM A→G E→G
1334 ENV G→T K→N
1428 ENV T→G S→A
1796 ENV T→C None
4572 NS2B C→T None
6720 NS4A T→A T→A
6968 NS4B T→A V→E
7533 NS4B A→C I→L
a Sequence obtained only for regions where changes had been identified in
SLEV CP40.region which has no known role in replication. This was the
only mutation identified in the full-genome analysis of WNV
CP19. All mutations in WNV were confirmed in a second
distinct lineage. Three of the six nonsynonymous changes
found in SLE CP40 occurred in the NS4A region, one of which
was confirmed in SLE CP20. Two amino acid changes in the
envelope region were generated in SLE CP40, while one was
found in the prM region. Of these three changes, only the prM
mutation was also found in SLE CP20. The prM change and
envelope change at position 1428 were both nonconservative
amino acid changes.
Discussion
We have developed an in vitro system to measure relative
fitness of two flaviviruses, which was modified from a method
developed for VSV (Holland et al., 1991). The system is based
on the development of surrogate wild-type MARM viruses that
replicate similarly to those of the test viruses and can be
accurately distinguished during competition assays. As a
validation of the plaque assay results, we demonstrated that
patterns of fitness change could also be measured by RT-PCR.
We also performed viral growth curve analyses and demon-
strated that, although changes in relative fitness often are
reflected in growth patterns, there are inconsistencies between
the two complementary methods that reflect the importance of
each. Using these methods, we sought to clarify the contribu-
tions of an individual host cell type to adaptation and viral
evolution of WNV and SLEV.
Alternate replication in vertebrates and invertebrate vectors
has been hypothesized to explain the evolutionary stability of
WNV and other arboviruses (Scott et al., 1994; Weaver et al.,
1992). This hypothesis implies a compromise between
presumably nonintersecting fitness peaks, which in turn
slows accumulation of mutations that are exclusively advanta-
geous to either vertebrate or vector. The experiments presented
here demonstrate that both WNV and SLEV, after serial
passage in mosquito cell culture, showed large relative fitness
gains in the homologous system (mosquito cells) that did not
correspond to gains in an alternate system (avian cell culture).
This cell-specific adaptation in fitness was also reflected in
virus replicative ability. Although the two flaviviruses, WNV
and SLEV, are closely related genetically and structurally,
SLEV showed an ability to adapt more quickly and to attain
larger gains in fitness than did WNV. Furthermore, more
mutations (8 vs. 3) were generated in SLE CP40 than in WNV
CP39. This result is somewhat surprising, given the fact that
SLEV had consistently grown to an approximately 1 log10
lower titer than WNV at the time of harvest (Fig. 4), and it
demonstrates that closely related RNA viruses may differ in
their rates of adaptation and evolution. These differences could
reflect the inherent robust and catholic nature of WNV as
compared with the specificity of SLEV. WNV has disseminated
rapidly and successfully throughout diverse ecological habitats
where it has infected a broad range of mosquito and bird
species worldwide (Hayes et al., 2005), while SLEV has a
much narrower host range (Monath, 1980).
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cells in which they were passed is consistent with findings of
studies done with two alphaviruses, EEEV and SINV, which
also exhibited cell-specific fitness gains (Greene et al., 2005;
Weaver et al., 1999; Cooper and Scott, 2001). The use of cell
culture passage producing virus strains which are attenuated in
other in vitro and in vivo systems is well documented for the
flaviviruses dengue and yellow fever (Barrett et al., 1990;
Butrapet et al., 2000; Halstead and Marchette, 2003). Dengue
studies, however, used cell culture systems that did not
represent natural host cell types and, therefore, give us little
insight into adaptations important in perpetuation of flaviviruses
in nature. Although some yellow fever studies passaged in a
relevant cell type, attenuation was measured only in vivo and,
therefore, results are not directly applicable to comparison with
the results presented here. The idea that alternating replication
constrains evolution predicts that a gain in fitness in the
invertebrate vector should result in a loss of fitness in the
vertebrate host. In contrast to the work of Weaver and
coworkers (1999), the gains in fitness for WNV and SLEV we
measured in mosquito cells do not correspond to large fitness
losses in a vertebrate (avian) cell line. Although fitness losses in
DF-1 cells were seen in most lineages, they were modest and
inconsistent. This difference could be attributed to the cell lines
used to represent the ‘bypassed’ portion of the transmission
cycle. For WNV, SLEV, EEEV and SINV, the natural reservoir
host is avian. Hamster cells (BHK) were used as ‘bypassed’ cell
line in the previous studies with EEE and SINV, whereas
chicken (DF-1) cells were used here. The lack of change in
avian cells could therefore be attributed to the inherent
adaptation of these viruses to their natural host cell type. The
failure to detect significant losses could also be attributed to the
adaptability of the virus population as a result of its genetic
diversity. It has been shown that WNV in nature exists as highly
diverse populations (Jerzak et al., 2005), a characteristic typical
of RNA viruses (Domingo et al., 1998; Eigen, 1993; Eigen and
Biebricher, 1988). This diversity could provide genetic variants
that allow rapid adaptability upon entry into a new environment.
If this is the case, some mutations may in fact be detrimental to
replication in vertebrate cells. However, this effect could not be
accurately measured without a genetically homogenous popula-
tion with these changes. The impact of WNV and SLEV
quasispecies on both fitness and population adaptability is
currently under investigation.
Studies with VSV suggest that arbovirus evolution is not
constrained by alternating cellular environments and, rather,
that virus populations are, in effect, generalists that find
replication in disparate cellular environments indistinguishable
(Novella et al., 1999). If this were the case for flaviviruses,
adaptation to mosquito cells should result in fitness gains in
avian cells. Although we did not measure substantial gains or
declines in viral fitness in avian cells, our results clearly indicate
that mosquito and avian cells do not constitute similar
environments for flavivirus replication. Additional studies
with VSV suggested that differences in replicative strategy
between invertebrate vectors (persistent replication) and
vertebrate hosts (acute infection) play a major role in shapingarbovirus evolution (Novella et al., 1995; Zarate and Novella,
2004). Since in our study all infections were acute, the results
clearly indicate that cell type is sufficient for specific adaptation
of flaviviruses. However, replicative strategy, together with the
further constraints of limited cell types in vitro, is a factor to
consider when assessing how the adaptation measured here is
applicable to the intricacy of adaptation in natural viral
populations. Further studies to investigate whether in vitro
adaptations translate to in vivo systems are in progress.
The relatively small number of consensus mutations, taken
together with the nature of the mutations (predominately
conservative) following sequential mosquito cell culture
passages, is not necessarily compatible with the idea that
evolutionary stability can be attributed to replication in
alternating environments. Nevertheless, the degree of genetic
change identified here agrees with that seen in previous studies
(Chen et al., 2003; Greene et al., 2005; Novella et al., 1999;
Weaver et al., 1999) and, without a comparison to alternating
environments, the constraints of cycling cannot be assessed
accurately. Though low in number, the genetic changes
measured here were coupled with profound phenotypic effects,
indicating that adaptation to a specific environment may
require very few changes in the consensus sequence. Such a
phenomenon has been observed with the dissemination of
WNV throughout North America, i.e., rapid success in a naive
environment with few changes in consensus sequence (Davis
et al., 2005). It also has been shown, for VSV, that fitness gains
can occur with no changes in consensus sequence (Novella and
Ebendick-Corp, 2004). For WNV, we confirmed the sequence
changes in a second distinct lineage. This suggests positive
selection for these changes and identifies them as potentially
significant in generating fitness advantages.
One and two synonymous mutations were detected in the
envelope region of WNV and SLEV, respectively. Our expecta-
tionwas that themajority of important changeswould accumulate
here due to this region's clearly defined role in binding and
replication (Chambers et al., 1990; Scherret et al., 2001).
Surprisingly, though, the amino acid changes common in both
WNVCP19 and CP39, and SLE CP20 and CP40, were not found
in the envelope region. In both WNV CP19 and SLE CP20, a
single amino acid change was found in the NS4A gene, a region
that has no known role in replication. Since this represents one of
two changes confirmed in SLE CP20 and the only change
identified in full-genome sequences of WNV CP19, it seems
plausible that this region is playing a role in creating fitness
advantages in mosquito cells. Furthermore, three of the six amino
acid changes identified in SLE CP40 were within the NS4 region
of the genome. Studies using reverse genetics are underway to
investigate the roles of NS4 and other potentially important genes
in flavivirus replication.
Materials and methods
Cells and media
African green monkey kidney cells (Vero, ATCC #CCL-81)
were grown in minimal essential medium (MEM, Gibco,
171A.T. Ciota et al. / Virology 357 (2007) 165–174Invitrogen Corp, Carlsbad, CA) supplemented with 10% fetal
bovine serum (FBS, Hyclone, Logan, UT), 2 mM L-glutamine,
1.5 g/l sodium bicarbonate, 100 U/ml of penicillin, and 100 μg/
ml of streptomycin. Aedes albopictus mosquito cells (C6/36,
ATCC #CRL-1660) were maintained in MEM supplemented
with 10% FBS, 2 mM L-glutamine, 1.5 g/l sodium bicarbonate,
0.1 mM non-essential amino acids, 100 U/ml of penicillin, and
100 μg/ml of streptomycin. Chicken embryo fibroblast cells
(DF-1, ATCC #CRL-12203, cell line derived from East
Lansing ELL-0 chicken eggs) were grown in DMEM (ATCC
#30-2002) supplemented with 10% FBS, 100 U/ml of
penicillin and 100 μg/ml of streptomycin. Vero, C6/36, and
DF-1 cells were grown and maintained at the optimum
temperature for each cell line: 37 °C, 28 °C, and 39 °C,
respectively. Confluent monolayers of each cell line were
prepared for infection by seeding six-well plates (Costar,
Corning, NY) with 6×105 cells/well in 3 ml of appropriate
media and incubating at the proper temperature for 3 days.
Confluent cell monolayers and virus-infected cells were
maintained in the appropriate media for the cell line,
supplemented with 2% FBS.
Virus strains and MAb
Biological clones of WNV (3356.1.1.1) and SLE Kern
(217.3.1.1) were isolated by three rounds of plaque purification
on Vero cells. WNV 3356.1.1.1 was derived from WNV
NY003356, a primary isolate from the kidney tissue of an
American crow that was collected in 2000 in Staten Island, NY
and prepared by one round of amplification in Vero cells (Ebel
et al., 2001). SLE Kern 217.3.1.1 was derived from the SLE
Kern 217 strain that was originally isolated in 1989 from Culex
tarsalis from Kern County, CA, and passaged twice in Vero
cells (obtained from Dr. William Reisen, University of
California at Davis; Kramer and Chandler, 2001). The
biological clones were propagated for use in these fitness
studies by two (WNV) or three (SLE) rounds of Vero cell
amplification and quantified by plaque assay on Vero cells
(Payne et al., 2006). Replication of biological clones was
compared to replication of original isolates in many in vitro and
in vivo systems, and no significant differences were identified
(data not shown). WNV and SLE MARMs were developed by
three rounds of plaque purification in Vero cells in the presence
of highly neutralizing MAb. MARM WNV 34.1 and SLE
MARM-8 were isolated in the presence of WNV MAb 5H10
(BioReliance Invitrogen Bioservices #81-003, Rockville, MD)
and SLE MAb 6B5A-2 (obtained from John Roehrig, Centers
for Disease Control and Prevention, Fort Collins, CO),
respectively. Sequence analysis demonstrated amino acid
substitutions T→ I at position 652 in the envelope of WNV
34.1 and L→P at position 388 in the envelope of SLE-MARM
8. MARM isolates were propagated for use in fitness studies by
two (WNV) or three (SLE) rounds of Vero cell amplification in
the presence of the appropriate MAb. All titrations of MARMs
were performed by plaque assay on Vero cells in the presence of
the appropriate MAb in the agar overlay to prevent phenotypic
mixing and masking (Holland et al., 1989). MARM titers wereidentical in the presence or absence of MAb. Multiple aliquots
of all viral stocks were stored frozen at −80 °C.
Serial passage of virus
Three lineages each of WNV 3356.1.1.1 and SLE Kern
217.3.1.1 were obtained by 40 serial passages in C6/36 cells,
using a multiplicity of infection (MOI) of 0.1 PFU/cell, based
on Vero cell titers, for each passage. Virus was adsorbed to
confluent cell monolayers in six-well plates for 1 h at 28 °C,
with frequent rocking. Following adsorption, the inoculum
was removed, cells were washed with MEM, 3 ml of
maintenance media was added, and plates were incubated at
28 °C. Medium from each well was harvested at 72 hpi and
stored, in aliquots, at −80 °C. Following each passage, the
viral harvest was quantified by plaque assay on Vero cells and
diluted to produce an MOI of 0.1 PFU/cell for each subsequent
passage.
Viral growth curve analysis
Six-well plates containing confluent monolayers of Vero,
C6/36, or DF-1 cells were infected with virus, in duplicate or
triplicate, at an MOI of 0.1 or 0.01 PFU/cell, based on Vero cell
titer. At the end of a 1 h absorption period at 37 °C (Vero), 28 °C
(C6/36), or 39 °C (DF-1), the inoculum was removed, 3 ml of
maintenance media was added to each well, and the plates were
returned to the appropriate temperatures. Samples, consisting of
100 μl of media, were taken at 12, 24, 36, 48, 72, 96, and
120 hpi, diluted 1:10 in BA-1 containing 20% FBS, and stored
at −80 °C. All samples were titered, in duplicate, by plaque
assay on Vero cells, and growth curves were constructed, using
the mean titer for each time point.
Determination of viral fitness by competition assay
Relative fitness of WNV and SLEV was evaluated by
competition assays in C6/36, Vero, and DF-1 cells, based, with
some modifications, on the protocol used by Holland et al.
(1991) for VSV. Briefly, confluent cell monolayers in six-well
plates were infected in triplicate with a mixture of control and
test virus at an MOI of 0.01 PFU/cell, based on Vero cell titer.
The controls were WNV MARM and SLEV MARM, each
serving as surrogate wild-type virus. The test virus consisted of
WNV or SLEV biological clones before and after passage in
C6/36 cells. The ratio of test:control virus in the inoculum
mixture used for the first competition round, determined by
preliminary assays, was 1:1 for all competition assays, except
for SLE in C6/36 cells, which was 1:4. After a 60-min absorp-
tion period at 28 °C (C6/36), 37 °C (Vero), or 39 °C (DF-1), the
infected monolayers were washed three times, overlaid with 3
ml of maintenance medium, and incubated at the temperatures
used for the infection. Medium from the infected cultures was
harvested at 48, 72, or 96 hpi, diluted 1:10 in growth medium
supplemented with 20% FBS, and frozen at −80 °C for later
titration, in duplicate, on Vero cells. The time of harvest for
each cell line was chosen from previous growth curves (Fig. 1).
Table 2
Primers used for full-genome sequencing of WNV and SLEV
WNV SLE
Primer name Sequence (5′–3′) Map position Primer name Sequence (5′–3′) Map position
WN1S AGTAGTTCGCCTGTGTGAGCTGAC 1–24 SLE1S ATGTTCGCGTTGGTGAGTGGAGAG 1–23
WN1R CAGACTGCTTCGTGGCGTGTG 1700–1720 SLE1R AACTGTTCCATACTCGCCCATGTTG 1496–1520
WN2S TCAGGCAGGGAGATTCAGC 1452–1470 SLE2S TTGGTGATCATGCTGATGCTGATT 924–947
WN2R GGTGGCGGTGAGGCGTTTAGGTG 2768–2790 SLE2R AACGTCGTTGTACACGAAGATGC 2518–2540
WN3S AAGGCTGTCCATCAAGTGTTC 2284–2305 SLE3S GGCACCACCCAGATTAACTACCAC 2127–2150
WN3R CCCACCAAGATGACATAGCGTAAC 3687–3710 SLE3R AGGCTGCTCCAATAACCATCAAGA 3835–3858
WN4S ATTGACTTCGATTACTGCCCAG 3292–3313 SLE4S GTGCGATACCTGGTCCTTGTTGG 3684–3706
WN4R ACCTCATCCTGCCCGTTCCACTTG 4872–4895 SLE4R AATCATTTGGACCTCCTCAGTTC 4867–4889
WN5S CAAGCAGGAGCGGGCGTGAT 4714–4733 SLE5S CAAAAGTGTATCCAAAGTGTGAGA 4624–4647
WN5R GATCCGAGTACACCCTGGCGTCAA 6401–6424 SLE5R ACGCAATCGAAACTCCCCATCC 6152–6173
WN6S CTACCAACCAGAGCGTGAGAA 6138–6158 SLE6S TGGACCCATGGCAATCACA 5927–5945
WN6R TACCCTCTGACTTCTTGGACTCTT 7965–7988 SLE6R CTGTTCTCCGCTGGGCTGCTCT 7308–7329
WN7S CAACAACTGCCATCGGACTC 7574–7593 SLE7S ATCTCAAGCTGGTGTACTGTTAG 7124–7147
WN7R GGCGCTCCTCCATTGATTC 8934–8952 SLE7R ACGTTCTGTATGGGTTGTTGTGGT 8560–8583
WN8S GTTCGCTGGTCAATGGAGTGGTCA 8639–8662 SLE8S ATGGGGAGGATGGACAAACAGA 8391–8412
WN8R TCCGATGATTGCTCTGACTTGGTT 10,297–10,320 SLE8R ACATAAGCAACCACATCTGAGCATAG 9956–9981
WN9S AGACAAAACCCCAGTGGAGAAATG 10,170–10,193 SLE9S CCCTTCTGCTCACACCACTTCAAT 9804–9827
WN9R AGATCCTGTGTTCTCGCACCACCA 11,006–11,029 SLE9R GGGTCTCCTCTAACCTCTAG 10,794–10,814
172 A.T. Ciota et al. / Virology 357 (2007) 165–174A total of three or four successive competition rounds were
carried out, using Vero cell titers by plaque assay or fluorescent
focus assay (Payne et al., 2006), to determine the dilution
needed to maintain an MOI of 0.01 PFU/cell. The purpose of
using multiple rounds of competition was to correct for random
fluctuations in ratios which could be misinterpreted as fitness
changes if a single passage of competition was used. Multiple
rounds of competition allowed construction of vector plots
which accurately measure changes in fitness. This is particu-
larly important in validating modest changes. The competition
assays were evaluated by measuring the amount of control and
test virus present in the initial input mixture, and at the end of
each competition round, by duplicate plaque assay on Vero
cells, in the presence and absence of highly neutralizing MAb
in the agar overlay. The quantity of test virus was obtained by
subtracting the titer in the presence of MAb (MARM control
titer) from the titer without MAb (total titer), and the ratio of
test:control virus was determined for each of the three
competition round replicates. Fitness vector plots were
constructed by normalizing the ratio for each round of infection
to the ratio of the initial input and plotting log10 transformed
values against the competition round. Relative fitness values
were obtained from the slope of each vector line (Duarte et al.,
1992; Martinez et al., 1991). Post tests following regression
analysis were performed to confirm that no data set was
significantly nonlinear (GraphPad Prism, Version 4.0). This
allowed us to confidently conclude that relative fitness changes
quantified were a result of passaging and not subsequent
rounds of competition. The slopes were then compared by
ANCOVA to determine whether significant fitness changes had
occurred (P<0.05).
Competition assays of C6/36-passed SLEV in C6/36 cell
culture also were analyzed by real-time RT-PCR, using primer-
probe sets designed to distinguish between the envelope regions
of SLE MARM-8 and Kern 217.1.1.1. MARM-8 was detectedwith forward primer 5′-AGT-ATT-GTT-ACG-AAG-CAA-
CTT-TGG-A, reverser primer 5′-TCT-CCT-GTT-GTA-GGG-
CAC-CTT, and TaqMan probe 6FAM-ACG-CCG-TCA-ACA-
GTG-NFQ. Kern 217.1.1.1 was detected with forward primer
5′-CGT-GAG-TAT-TGT-TAC-GAA-GCA-ACC-T, reverser
primer 5′-TCT TCT-CCT-GTT-GTA-GGG-CAC-CTT, and
TaqMan probe 6FAM-ACA-CGC-TGT-CAA-CAG-TG-NFQ.
RT-PCR assays were performed on an ABI Prism 7700
sequence detector, using TaqMan one-step RT-PCR master
mix (Applied Biosystems, Foster City, CA), as previously
described (Shi et al., 2001).
Sequencing
RNA was extracted from WNV and SLEV using RNeasy
spin columns (Qiagen, Valencia, CA) according to manufac-
turer's protocol. Primers for WNV were designed from
GenBank AF260967, and for SLEV, from M16614 and
AF1160194. One-step RT-PCR (Qiagen) was conducted
using primers (Table 2) to generate nine overlapping PCR
products. Reverse transcription reactions were carried out at
50 °C for 30 min followed by inactivation of the
transcriptase at 95 °C for 15 min. Amplification was then
carried out for 40 cycles at 94 °C for 20 s, 5 °C for 30 s, 72
°C for 2 min, with final elongation at 72 °C for 10 min. PCR
products were visualized on a 1.5% gel, and then bands were
then allowed to run through 1% Nusieve GTG low-melting
agarose (Cambrex BioScience, Rockland, ME). Sequencing
was performed with ABI 3700 automated sequencers
(Applied Biosystems) using overlapping primers to give a
minimum of two-fold redundancy. Sequences were compiled
and edited by using DNASTAR software package (Madison,
WI). Novel full-length sequence generated for SLE 217.3.1.1
was deposited into GenBank under accession number
DQ525916.
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